BIOLASE Balance Sheet Health

Financial Health criteria checks 2/6

BIOLASE has a total shareholder equity of $-2.1M and total debt of $13.4M, which brings its debt-to-equity ratio to -631.5%. Its total assets and total liabilities are $30.6M and $32.8M respectively.

Key information

-631.5%

Debt to equity ratio

US$13.43m

Debt

Interest coverage ration/a
CashUS$5.27m
Equity-US$2.13m
Total liabilitiesUS$32.77m
Total assetsUS$30.64m

Recent financial health updates

Recent updates

Biolase partners with dental speciality programs across U.S.

Aug 31

BIOLASE: Ongoing Operating Losses, Capital Raises To Sustain Liquidity

Jul 21

BIOLASE amends senior secured term loan with SWK Funding

Jul 01

BIOLASE: Bad News Across The Board - Sell

Mar 21

Is BIOLASE (NASDAQ:BIOL) Weighed On By Its Debt Load?

Feb 24
Is BIOLASE (NASDAQ:BIOL) Weighed On By Its Debt Load?

BIOLASE - Speculative Buy After Strong Preliminary Q4 Results

Jan 11

BIOLASE - Good News Across The Board But Still Only Suited For The Most Speculative Investors

Nov 24

Financial Position Analysis

Short Term Liabilities: BIOL.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: BIOL.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: BIOL.Q has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: BIOL.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BIOL.Q has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: BIOL.Q is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies